MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,510K
Net Income
$74,141K
Net Profit Margin
2953.82%
EPS
-$0.27
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Grant and award revenue
2,510
789
1,085
1,159
Research and development
7,586
6,111
6,070
5,824
General and administrative
5,236
3,463
3,426
3,111
Impairment expense
-
-
5,412
-
Total operating expenses
12,822
9,574
14,908
8,935
Operating loss
-10,312
-8,785
-13,823
-7,776
Interest income
69
60
131
90
Interest expense
6,634
5,559
4,834
4,346
Change in fair value of the convertible loan
91,018
-101,062
-105,772
-14,643
Total other income (expense), net
84,453
-106,561
-110,475
-18,899
Net income (loss)
74,141
-115,346
-124,298
-26,675
Basic EPS
2.02
-3.16
-3.419
-0.74
Diluted EPS
-0.27
-3.16
-3.43
-0.74
Basic Average Shares
36,747,840
36,530,284
36,352,446
36,226,285
Diluted Average Shares
62,041,700
36,530,284
36,239,253*
36,226,285
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
the convertible...
$91,018K
(1682.65%↑ Y/Y)
Interest income
$69K
(-36.11%↓ Y/Y)
Total other income
(expense), net
$84,453K
(993.59%↑ Y/Y)
Interest expense
$6,634K
(74.21%↑ Y/Y)
Net income (loss)
$74,141K
(554.99%↑ Y/Y)
Operating loss
-$10,312K
(-50.67%↓ Y/Y)
Grant and award
revenue
$2,510K
(15.72%↑ Y/Y)
Total operating
expenses
$12,822K
(42.26%↑ Y/Y)
Research and development
$7,586K
(18.64%↑ Y/Y)
General and
administrative
$5,236K
(99.92%↑ Y/Y)
Buy us a coffee
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP)